Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06228053
Title Study of SX-682 Plus Enzalutamide in Men With Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer (SYNERGY-201)
Acronym SYNERGY-201
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Syntrix Biosystems, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, Los Angeles NOT_YET_RECRUITING Los Angeles California 90095 United States Details
University of California, San Francisco RECRUITING San Francisco California 94143 United States Details
University of Michigan RECRUITING Ann Arbor Michigan 48109 United States Details
University of Minnesota NOT_YET_RECRUITING Minneapolis Minnesota 55455 United States Details
Duke University NOT_YET_RECRUITING Durham North Carolina 27710 United States Details
University of Wisconsin NOT_YET_RECRUITING Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field